Tissue Diagnostics Market by Product(Antibodies, Kits, Slide Staining System, Tissue Processing System), Technology(ISH, IHC, Special Staining), Disease(Breast Cancer, NSCLC, Lymphoma), End User (Hospitals, Research Laboratories) - Global Forecast to 2027
Description
Tissue Diagnostics Market by Product(Antibodies, Kits, Slide Staining System, Tissue Processing System), Technology(ISH, IHC, Special Staining), Disease(Breast Cancer, NSCLC, Lymphoma), End User (Hospitals, Research Laboratories) - Global Forecast to 2027
The global Tissue Diagnostics market is growing at a CAGR of 6.6% during and it is expected to reach USD 7.3 billion by 2027 from USD 5.3 billion in 2022, during the forecast period. The expansion of this market is majorly due to rising prevalence of neoplastic cases as well as high demand of oncology screening, However, Lack of skilled professionals is one of the challenge for which may inhibit the growth of this market.
“The Slide-Staining Systems in instruments is projected to grow at CAGR of 7.4% from 2022 to 2027”
Based on the product, the tissue diagnostics market is classified into tissue diagnostics consumables (Antibodies, Kits, Reagents, Probes) and tissue diagnostics Instruments (Slide-staining Systems, Scanners, Tissue-processing Systems, Other Instruments). The growth of this market is majorly driven by the factors such as benefits of automation, the greater capacity of slide staining systems, and the elimination of manual errors, and delivering high throughput staining capabilities for histology laboratories.
“Asia Pacific is estimated to register the highest CAGR during the forecast period.”
In this report, the tissue diagnostics market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the economic growth in the countries of this region, large population base, the rising prevalence of chronic diseases, the rising standard of living, growing demand for quality medical care, increasing healthcare spending, increasing government initiatives, and rising awareness regarding the use of tissue diagnostic tests
Breakdown of supply-side primary interviews, by company type, designation, and region:
By Company Type: Tier 1 (32%) , Tier 2 (44%), and Tier 3 (24%)
By Designation: C-level (30%), Director-level (34%), and Others (36%)
By Region: North America (40%), Europe (28%), AsiaPacific (20%), and Rest of the World(12%)
List of Companies Profiled in the Report
F. Hoffmann-La Roche Ltd. (Switzerland)
Danaher Corporation (US)
Thermo Fisher Scientific, Inc (US)
Abbott (US)
Agilent Technologies Inc. (US)
Merck KGAA (Germany)
SAKURA FINETEK JAPAN CO., LTD (Japan)
Abcam Plc. (UK)
Becton, Dickinson and Company (BD) (US)
Bio SB (US)
Biogenix (US)
Cell Signaling Technology, Inc (US)
Histo-Line Laboratories (Italy)
SLEE Medical GMBH (Germany)
Hologic Inc. (US).
Jinhua YIDI Medical Appliance Co. Ltd (China)
MEDITE MEDICAL GMBH (Germany)
Cellpath Ltd (UK)
Amos scientific Pty Ltd (Australia)
Dipath S.P.A (Italy)
KFBIO KONFOONG BIOINFORMATION TECH CO
LTD (China), Diagnostic BioSystems Inc. (US)
3DHISTECH LTD (Hungary)
RWD LIFE SCIENCE CO., LTD. (China)
Dakewe Biotech Co., Ltd. (China)
Research Coverage:
This report studies the tissue diagnostics market based on product, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total tissue diagnostics market. The report forecasts the revenue of the market segments with respect to five major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on tissue diagnostics products offered by the top 25 players in the tissue diagnostics market. The report analyzes the tissue diagnostics market by product, and region.
Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.
Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the tissue diagnostics market
Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the tissue diagnostics market
The global Tissue Diagnostics market is growing at a CAGR of 6.6% during and it is expected to reach USD 7.3 billion by 2027 from USD 5.3 billion in 2022, during the forecast period. The expansion of this market is majorly due to rising prevalence of neoplastic cases as well as high demand of oncology screening, However, Lack of skilled professionals is one of the challenge for which may inhibit the growth of this market.
“The Slide-Staining Systems in instruments is projected to grow at CAGR of 7.4% from 2022 to 2027”
Based on the product, the tissue diagnostics market is classified into tissue diagnostics consumables (Antibodies, Kits, Reagents, Probes) and tissue diagnostics Instruments (Slide-staining Systems, Scanners, Tissue-processing Systems, Other Instruments). The growth of this market is majorly driven by the factors such as benefits of automation, the greater capacity of slide staining systems, and the elimination of manual errors, and delivering high throughput staining capabilities for histology laboratories.
“Asia Pacific is estimated to register the highest CAGR during the forecast period.”
In this report, the tissue diagnostics market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the economic growth in the countries of this region, large population base, the rising prevalence of chronic diseases, the rising standard of living, growing demand for quality medical care, increasing healthcare spending, increasing government initiatives, and rising awareness regarding the use of tissue diagnostic tests
Breakdown of supply-side primary interviews, by company type, designation, and region:
By Company Type: Tier 1 (32%) , Tier 2 (44%), and Tier 3 (24%)
By Designation: C-level (30%), Director-level (34%), and Others (36%)
By Region: North America (40%), Europe (28%), AsiaPacific (20%), and Rest of the World(12%)
List of Companies Profiled in the Report
F. Hoffmann-La Roche Ltd. (Switzerland)
Danaher Corporation (US)
Thermo Fisher Scientific, Inc (US)
Abbott (US)
Agilent Technologies Inc. (US)
Merck KGAA (Germany)
SAKURA FINETEK JAPAN CO., LTD (Japan)
Abcam Plc. (UK)
Becton, Dickinson and Company (BD) (US)
Bio SB (US)
Biogenix (US)
Cell Signaling Technology, Inc (US)
Histo-Line Laboratories (Italy)
SLEE Medical GMBH (Germany)
Hologic Inc. (US).
Jinhua YIDI Medical Appliance Co. Ltd (China)
MEDITE MEDICAL GMBH (Germany)
Cellpath Ltd (UK)
Amos scientific Pty Ltd (Australia)
Dipath S.P.A (Italy)
KFBIO KONFOONG BIOINFORMATION TECH CO
LTD (China), Diagnostic BioSystems Inc. (US)
3DHISTECH LTD (Hungary)
RWD LIFE SCIENCE CO., LTD. (China)
Dakewe Biotech Co., Ltd. (China)
Research Coverage:
This report studies the tissue diagnostics market based on product, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total tissue diagnostics market. The report forecasts the revenue of the market segments with respect to five major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on tissue diagnostics products offered by the top 25 players in the tissue diagnostics market. The report analyzes the tissue diagnostics market by product, and region.
Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.
Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the tissue diagnostics market
Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the tissue diagnostics market
Table of Contents
240 Pages
- STUDY OBJECTIVES
- MARKET DEFINITION
- MARKET SCOPE
- CURRENCY
- LIMITATIONS
- MARKET STAKEHOLDERS
- SUMMARY OF CHANGES
- RESEARCH DATA
- MARKET SIZE ESTIMATION
- MARKET BREAKDOWN AND DATA TRIANGULATION
- MARKET SHARE ANALYSIS
- ASSUMPTIONS FOR THE STUDY
- INDICATORS AND ASSUMPTIONS AND THEIR IMPACT ON THE STUDY
- RISK ASSESSMENT
- EXECUTIVE SUMMARY
- TISSUE DIAGNOSTICS MARKET OVERVIEW
- TISSUE DIAGNOSTICS MARKET, BY PRODUCT
- ASIA PACIFIC: TISSUE DIAGNOSTICS MARKET, BY DISEASE & COUNTRY
- GEOGRAPHIC SNAPSHOT OF TISSUE DIAGNOSTICS MARKET
- INTRODUCTION
- MARKET DYNAMICS
- COVID-19 IMPACT ON TISSUE DIAGNOSTICS MARKET
- RANGES/SCENARIOS
- VALUE CHAIN ANALYSIS
- SUPPLY CHAIN ANALYSIS
- TECHNOLOGY ANALYSIS
- PORTER’S FIVE FORCES ANALYSIS
- KEY STAKEHOLDERS & BUYING CRITERIA
- REGULATORY LANDSCAPE
- PATENT ANALYSIS
- KEY CONFERENCES & EVENTS IN 2022-2023
- PRICING ANALYSIS
- TRADE ANALYSIS
- ECOSYSTEM ANALYSIS
- TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
- INTRODUCTION
- CONSUMABLES
- INSTRUMENTS
- INTRODUCTION
- IMMUNOHISTOCHEMISTRY (IHC)
- IN SITU HYBRIDIZATION (ISH)
- DIGITAL PATHOLOGY & WORKFLOW MANAGEMENT
- SPECIAL STAINING
- INTRODUCTION
- BREAST CANCER
- GASTRIC CANCER
- LYMPHOMA
- PROSTATE CANCER
- NON-SMALL CELL LUNG CANCER
- OTHER DISEASES
- INTRODUCTION
- HOSPITALS
- RESEARCH LABORATORIES
- PHARMACEUTICAL COMPANIES
- CONTRACT RESEARCH ORGANIZATIONS
- OTHER END USERS
- INTRODUCTION
- NORTH AMERICA
- EUROPE
- ASIA PACIFIC
- REST OF THE WORLD
- OVERVIEW
- KEY PLAYER STRATEGIES/RIGHT TO WIN
- REVENUE SHARE ANALYSIS
- MARKET SHARE ANALYSIS
- COMPANY EVALUATION QUADRANT
- COMPANY EVALUATION QUADRANT FOR SMES/START-UPS
- COMPANY FOOTPRINT ANALYSIS
- COMPETITIVE BENCHMARKING
- COMPETITIVE SCENARIO
- KEY PLAYERS
- INDUSTRY INSIGHTS
- DISCUSSION GUIDE
- KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
- AVAILABLE CUSTOMIZATIONS
- RELATED REPORTS
- AUTHOR DETAILS
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
